Vincerx Pharma Inc

Company Profile

Vincerx Pharma Inc had its IPO on 2020-05-27 under the ticker symbol VINC.

The company operates in the Healthcare sector and Biotechnology industry. Vincerx Pharma Inc has a staff strength of 41 employees.

Stock update

Shares of Vincerx Pharma Inc opened at $0.75 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.73 - $0.75, and closed at $0.73.

This is a 0% increase from the previous day's closing price.

A total volume of 19,715 shares were traded at the close of the day’s session.

In the last one week, shares of Vincerx Pharma Inc have increased by +2.53%.

Vincerx Pharma Inc's Key Ratios

Vincerx Pharma Inc has a market cap of $15.50 million, indicating a price to book ratio of 0.2284 and a price to sales ratio of 0.

In the last 12-months Vincerx Pharma Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-57720000. The EBITDA ratio measures Vincerx Pharma Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Vincerx Pharma Inc’s operating margin was 0% while its return on assets stood at -58.7% with a return of equity of -113.74%.

In Q2, Vincerx Pharma Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Vincerx Pharma Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.53 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vincerx Pharma Inc’s profitability.

Vincerx Pharma Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0.6727. Its price to sales ratio in the trailing 12-months stood at 0.

Vincerx Pharma Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$35.28 million

Total Liabilities

$9.16 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Vincerx Pharma Inc ended 2024 with $35.28 million in total assets and $0 in total liabilities. Its intangible assets were valued at $35.28 million while shareholder equity stood at $24.14 million.

Vincerx Pharma Inc ended 2024 with $0 in deferred long-term liabilities, $9.16 million in other current liabilities, 2000.00 in common stock, $-146830000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $6.68 million and cash and short-term investments were $27.36 million. The company’s total short-term debt was $1,092,000 while long-term debt stood at $0.

Vincerx Pharma Inc’s total current assets stands at $31.81 million while long-term investments were $0 and short-term investments were $20.68 million. Its net receivables were $1.38 million compared to accounts payable of $3.53 million and inventory worth $-748000.00.

In 2024, Vincerx Pharma Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Vincerx Pharma Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.73

52-Week High

$1.95

52-Week Low

$0.631

Analyst Target Price

$6.67

Vincerx Pharma Inc stock is currently trading at $0.73 per share. It touched a 52-week high of $1.95 and a 52-week low of $1.95. Analysts tracking the stock have a 12-month average target price of $6.67.

Its 50-day moving average was $0.99 and 200-day moving average was $1.14 The short ratio stood at 0.66 indicating a short percent outstanding of 0%.

Around 2596.4% of the company’s stock are held by insiders while 6047% are held by institutions.